Fisetin Attenuates Myocardial Ischemia-Reperfusion Injury by Activating the Reperfusion Injury Salvage Kinase (RISK) Signaling Pathway.

Shanmugam, Karthi; Boovarahan, Sri Rahavi; Prem, Priyanka; Sivakumar, Bhavana; Kurian, Gino A

Shanmugam, Karthi; Boovarahan, Sri Rahavi; Prem, Priyanka; Sivakumar, Bhavana; Kurian, Gino A.

Afiliação

Shanmugam K; School of Chemical and Biotechnology, SASTRA Deemed University, Thanjavur, India.
Boovarahan SR; Vascular Biology Lab, SASTRA Deemed University, Thanjavur, India.
Prem P; Vascular Biology Lab, SASTRA Deemed University, Thanjavur, India.
Sivakumar B; Vascular Biology Lab, SASTRA Deemed University, Thanjavur, India.
Kurian GA; Vascular Biology Lab, SASTRA Deemed University, Thanjavur, India.

Front Pharmacol ; 12: 566470, 2021.

Article em En | MEDLINE | ID: mdl-33762932

Palavras-chave

GSK3ß = glycogen synthase kinase-3ß; PI3K/Akt (PKB) axis; SB216763 GSK inhibitor; cardioprotection; fisetin (PubChem CID, 5281614); ischemia-reperfusion injury (I/R); reperfusion injury salvage kinase (RISK) pathway; wortmannin (PubChem CID, 312145)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google